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Feasibility of rehabilitation training with a newly developed wearable robot for patients 
with limited mobility  
ABSTRACT 
Objectives: To investigate the feasibility of rehabilitation training with a new wearable robot 
Design: Before-after clinical intervention 
Setting: University Hospital and private rehabilitation facilities 
Participants: A convenience sample of 38 patients with limited mobility. The underlying 
diseases were stroke (n = 12), spinal cord injuries (n = 8), musculoskeletal diseases (n = 4), and 
other diseases (n = 14). 
Interventions: The patients received 90-minute training with a wearable robot twice per week 
for 8 weeks (16 sessions). 
Main Outcome Measures: Functional ambulation was assessed with the 10-m walk test 
(10MWT) and the timed-up and go (TUG) test, and balance ability was assessed with the Berg 
balance scale (BBS). Both assessments were performed at the baseline and after the 
rehabilitation. 
Results: Thirty-two patients completed 16 sessions of the training with the wearable robot. The 
results of the 10MWT included significant improvements in gait speed, number of steps, and 
cadence. Although improvements were observed, as measured with the TUG test and BBS, the 
results were not statistically significant. No serious adverse events were observed during the 
training. 
Conclusions: Eight weeks of rehabilitative training with the wearable robot (16 sessions of 90 
minutes) could be performed safely and effectively, even many years after the subjects received 
their diagnosis. 
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ABBREVIATIONS 
HAL: Hybrid assistive limb 
10MWT: 10-m walk test 
TUG: Timed up-and-go 
BBS: Berg balance scale 
SCI: Spinal cord injury 
MADS: Musculoskeletal Ambulation Disability Symptom Complex 
CVC: Cybernic Voluntary Control 
CAC: Cybernic Autonomous Control 
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 2 
Rehabilitation robotics emerged in the 1980s with the aim of using robotic technology to assist 3 
people with movement dysfunction.1 Robotic devices have recently been developed for use in 4 
clinical settings. Tefertiller et al. reviewed 30 articles (14 randomized controlled trials, 16 non- 5 
randomized controlled trials) that examined the effects of locomotor training with robotic 6 
assistance in patients following stroke, spinal cord injury (SCI), multiple sclerosis, traumatic 7 
brain injury, and Parkinson’s disease. The review supports the conclusion that locomotor training 8 
with robotic assistance is beneficial for improving walking function in individuals following 9 
stroke and SCI.2 The development of main gait training machines followed. These machines 10 
either involve an exoskeleton robotic device (e.g., Lokomat, LOPES exoskeleton robot)3-4 or a 11 
robotic device with foot-driven plates (e.g., Gait Trainer GT I, Haptic Walker).5-6 The 12 
exoskeleton robotic device is equipped with programmable drives or passive elements that flex 13 
the knees and hips during the swing phase, whereas with the other type of robotic device, the feet 14 
are placed on foot plates, whose trajectories simulate the stance and swing phases. Other than 15 
robotic gait training and conventional therapy, another treatment approach involves treadmill 16 
training with partial body weight support (BWSTT).7 However, this approach requires 17 
considerable involvement of a physical therapist, and, generally, 3 therapists are required to 18 
induce movement of the paretic leg during the swing phase and to shift the patient's weight onto 19 
the stance limb.  20 
 21 
The potentially positive common benefits of robotic gait training are that it involves repeatedly 22 
undergoing sufficient and accurate training for a prolonged period. Lokomat (Hocoma, 23 
Volketswil, Switzerland) is the first robotic-driven gait orthosis with electromechanical drives to 24 
assist the walking movements of gait-impaired patients on a treadmill by supporting the body 25 
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weight.8-9 Husemann et al. compared a Lokomat group that received 30 minutes of robotic 26 
training with a control group that received 30 minutes of conventional physiotherapy10. After 4 27 
weeks of therapy, although there was no significant difference in walking ability between the 28 
groups, the walking ability in both groups as expressed by functional ambulation classification 29 
was significantly improved. The researchers reported that the Lokomat group demonstrated an 30 
advantage for robotic training over conventional physiotherapy in the improvement of gait 31 
abnormality and body tissue composition.10 However, in a recent randomized controlled study 32 
that compared robot-assisted locomotor training with therapist-assisted locomotor training in 33 
chronic stroke patients, the results indicated that greater improvements in speed and single limb 34 
stance time on the impaired leg were observed in subjects who received therapist-assisted 35 
locomotor training.11 Thus, the usefulness of robot-assisted rehabilitation is controversial. 36 
 37 
The robot suit hybrid assistive limb (HAL) 12-15,a is a new wearable robot that has a hybrid 38 
control system comprised of two subsystems: Cybernic Voluntary Control (CVC) and Cybernic 39 
Autonomous Control (CAC) (fig 1). The HAL suit has power units and force-pressure sensors in 40 
the shoes. The power units consist of angular sensors and actuators on bilateral hip and knee 41 
joints. Muscle action potentials are detected through the electrodes on the anterior and posterior 42 
surface of the wearer’s thigh. These various biological signals are processed by a computer. The 43 
HAL suit can support the wearer’s motion by adjusting the level and timing of the assistive 44 
torque provided to each joint according to the surface muscle action potential as well as the 45 
pressure sensors. The HAL suit can enhance the wearer’s motion through the wearer’s muscle 46 
action potential; thus, the HAL suit can appear as an actual motion. Therefore, if the wearer’s 47 
muscle action potential varies, the wearer’s motion varies, too. The HAL training, using muscle 48 
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activity, has the potential to intensify the feedback by evoking by an appropriate motion more 49 
strongly than standard robot training. Thus, after HAL training, patients with limited mobility 50 
will improve their walking abilities (gait speed, number of steps, cadence, or ability to transfer). 51 
 52 
Few studies have been conducted to clarify the feasibility of rehabilitation with HAL. Only 1 53 
preliminary study has reported on the short-term effects of HAL on the walking pattern of stroke 54 
patients.16 The purpose of the present study was to investigate the feasibility of 16-session (8-55 
week) HAL rehabilitation training for patients with limited mobility.  56 
 57 
METHODS 58 
Study design 59 
 60 
A quasi-experimental study was utilized, with measurements before and after the clinical 61 
intervention. The target population included patients with limitations in their walking (no matter 62 
the diagnosis, the time since the diagnosis and diagnosis age). The protocol of this study was 63 
approved by the Institutional Review Board of the University of Tsukuba Hospital and was 64 
registered with the UMIN Clinical Trials Registry (UMIN000002969). The clinical intervention 65 
was conducted at the University of Tsukuba Hospital and Cyberdyne, Inc. in Japan between 66 
January 2010 and March 2012. The patients included in this study were volunteers recruited 67 
through local newspaper advertisements or outpatients at the University of Tsukuba Hospital. 68 
They were informed about the aim and design of this study, and they subsequently provided 69 
written, informed consent. Informed consent was also obtained from the patient’s guardian if the 70 
patient was younger than 20 years old. 71 
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 73 
The inclusion criteria were (1) musculoskeletal ambulation disability symptom complex 74 
(MADS) or the underlying disorders of MADS, which is a condition newly defined in 2006 by 75 
Japanese medical societies;17 (2) requiring physical assistance or assistive devices in at least one 76 
of the following daily activities: standing up, sitting down, and walking; (3) ability to understand 77 
an explanation of the study and to express consent or refusal; (4) body size that can fit in the 78 
robotic suit HAL (height range of 145 - 180 cm, and maximal body weight of 80 kg); and (5) 79 
ability to undergo usual physical and occupational therapies. The exclusion criteria were the 80 
following: (1) inadequately controlled cardiovascular disorders; (2) inadequately controlled 81 
respiratory disorders; (3) intellectual impairments that limit the ability to understand instructions; 82 
(4) moderate to severe articular disorders, including contracture in the lower extremities; (5) 83 
moderate to severe involuntary movements, ataxia, or impairments of postural reflex in the trunk 84 
or the lower extremities; and (6) severe spasticity in the lower extremities. 85 
 86 
Participants 87 
 88 
Thirty-eight patients (25 men, 13 women) were enrolled in this study (24 outpatients, 14 89 
volunteers through advertisements). The mean age of the 38 patients was 53.2 ± 17.8 y, with a 90 
range of 18–81 y. Table 1 summarizes their clinical characteristics. Their underlying diseases 91 
were stroke (10 men, 2 women), SCI (6 men, 2 women), musculoskeletal diseases (2 men, 2 92 
women), and other diseases (Parkinson’s disease, gonadotropin-dependent myopathy, limb-93 
girdle muscular dystrophy, inclusion body myositis, traumatic brain injury, disuse syndrome, 94 
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secondary to malignant lymphoma, cerebral palsy, sequelae of poliomyelitis, and hypoxic 95 
ischemic encephalopathy; 7 men, 7 women). Twenty patients were able to ambulate 96 
independently without any help (n = 9) or with several assistive devices (t-cane, bilateral 97 
crutches, or lateral crutch) (n = 11). Eleven patients were able to ambulate with several assistive 98 
devices and under supervision. Three patients required human assistance to ambulate at least 10 99 
m (cases 33, 34, and 38), and the remaining 4 patients were unable to ambulate even with 100 
assistive devices and human assistance (cases 8, 15, 17, and 27). All of the stroke and SCI 101 
patients were in chronic stages. 102 
 103 
Training Program 104 
 105 
HAL training was administered twice per week for 8 weeks (16 sessions). The 90-minute 106 
training sessions consisted of single-leg motion, a standing and sitting exercise, and walking on 107 
the ground with HAL. For safety reasons, a walking device (All-in-One Walking Trainerb) with a 108 
harness was used. Treadmill training with mild body-weight support (Unweighing Systemc) was 109 
also used for some patients. The HAL suit has a hybrid control system comprising the CVC and 110 
CAC. The CVC mode of the HAL suit can support the patient’s voluntary motion according to 111 
the voluntary muscle activity and the assistive torque provided to each joint. The CAC mode 112 
provides physical support autonomously, based on output from force-pressure sensors in the 113 
shoes. This study mainly used the CVC mode, which allows the operator to adjust the degree of 114 
physical support to the patient’s comfort and gradually reduce support as training progresses. 115 
 116 
Outcome Measures 117 
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 118 
The feasibility of HAL rehabilitation with HAL was assessed by the number of completers and 119 
the amount of time or the number of therapists needed to implement training. Patients were asked 120 
to report adverse events during the training period. 121 
 122 
The primary outcomes were functional ambulation and balance ability. Functional ambulation 123 
was assessed with a 10-m walk test (10MWT) and a timed up-and-go (TUG) test. In the 10MWT, 124 
patients were instructed to walk without wearing HAL on a flat surface at their self-selected 125 
comfortable pace. Patients began to walk before they reached the starting line of the 10 m 126 
distance so that they could accelerate and attain a stable speed before the test. To calculate gait 127 
speed (m/s) as a primary outcome, the 10-m walking time was measured using a handheld 128 
stopwatch. In addition, the number of steps between the start and finish line was counted, and 129 
patient cadence was calculated from the walking time and number of steps. Patients were 130 
allowed to use their assistive device and/or lower limb orthosis as necessary. Each patient used 131 
the same assistive device and/or orthosis during the pre- and post-intervention measurements. 132 
Therapists closely attended the patients during the 10MWT but did not provide physical 133 
assistance. For each measurement, the 10MWT was performed twice. The faster time of two 134 
trials was selected for analysis. In the TUG test, the following actions were timed: standing up 135 
from a standard-height chair, walking 3 m, returning to the chair, and sitting down without HAL. 136 
Two trials (each turning clockwise and counterclockwise) were carried out for each measurement. 137 
Balance ability was assessed with the Berg balance scale (BBS), consisting of 14 tasks, as 138 
detailed by Berg et al.18 Each task was scored on a scale ranging from 0 to 4 points (0 indicates 139 
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inability to complete), and the total score was used as the index of balance ability. All primary 140 
outcomes were assessed at baseline and after completion of the 16 training sessions. 141 
 142 
Statistical Analysis 143 
 144 
All parametric data are expressed as means with standard deviations. Paired t tests were used to 145 
evaluate differences between the baseline measurements and outcomes after the 16 sessions. 146 
Unpaired t tests were used to evaluate the differences in characteristics of those who completed 147 
16 sessions and those who did not. An effect-size calculation (Cohen d) was used to assess the 148 
effect of the training. Pearson correlation coefficients were used to assess the relationship among 149 
outcome measures. Data were analyzed using IBM SPSS statistics 18 softwared, with the alphas 150 
level set at 5%. 151 
 152 
RESULTS 153 
 154 
A typical 90-minute HAL training session proceeded as follows: assessment of blood pressure, 155 
resting heart rate, and walking pattern (10 min); preparation of electrodes and putting on the 156 
HAL suit (5 min); computer set-up (5 min); HAL training (60 min, including resting time during 157 
computer operation); taking off the HAL suit and the electrodes (5 min); and reassessment of 158 
walking pattern (5 min). The net walking time was approximately 20 min. Typically, 2 therapists 159 
implemented the training: one supported the patient and the other operated the computer. All 160 
therapists and related staff had participated in a 3-h training workshop conducted by the 161 
manufacturer to learn how to operate the HAL system. 162 
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 163 
Of the 38 patients (25 men, 13 women), 32 (21 men, 11 women) completed all 16 training 164 
sessions. The mean age of the 32 patients was 53.2 ± 17.3 y, with a range of 18–81 y. There was 165 
no statistically significant difference in age between those who completed training and those who 166 
did not (54.0 ± 19.8 y). It took 10.0 ± 3.1 weeks (range, 8–21 weeks) to complete 16 sessions. Of 167 
the 6 patients who did not complete the 16 sessions, 2 (cases 15 and 21) dropped out for medical 168 
reasons, and 4 (cases 1, 2, 29, and 35) dropped out for personal reasons (difficulty visiting the 169 
hospital). One medical reason for dropout was low back pain that developed during the first 170 
training session (case 21); the patient withdrew consent at the third session. The other medical 171 
reason for dropout was a relapse (after the second session) of neuropathic pain due to SCI (case 172 
15); the patient withdrew consent at the fifth session. There were no serious training-related 173 
adverse events. One stroke patient (case 7) had knee pain (patellar tendinitis) at home after the 174 
15th session but was able to complete the 16th session after 1 month of rest. Another patient with 175 
inclusion body myositis (case 31) developed knee pain at home after an early session but was 176 
able to complete 16 sessions. 177 
 178 
Outcome Measures 179 
 180 
Functional ambulation was not assessed for 5 patients at baseline because 3 were unable to 181 
ambulate with any assistance (cases 8, 17, and 27), and the other 2 patients needed considerable 182 
human assistance to ambulate (cases 34 and 38). The other 27 patients presented significant 183 
improvements (P < 0.05) in gait speed, number of steps, and cadence after the 16-session HAL 184 
training (10MWT, table 2). Improvements in gait speed, number of steps, and cadence are 185 
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defined as an increase, a decrease, and an increase in the respective parameters. The mean 186 
improvements and effect sizes (Cohen d) in gait speed, number of steps, and cadence were 0.09 187 
± 0.11 m/s (d = 0.82), 3.0 ± 4.9 steps (d = 0.61), and 6.8 ± 7.1 steps/min (d = 0.96), respectively. 188 
Improvements in gait speed, steps, and cadence were observed in 25, 18, and 25 patients, 189 
respectively (figs 2–4). Worsened gait speed and cadence were observed in 2 patients (cases 28 190 
and 30). In the regards to the number of steps, we observed no change in 8 patients (cases 3, 5, 191 
16, 25, 28, 30, 33, and 37) and increased steps in 1 (case 20). Correlation coefficients for gait 192 
speed with number of steps and with cadence were r = 0.30 (not significant) and r = 0.73 (P < 193 
0.01), respectively. The effect sizes for gait speed in stroke patients (n = 9), SCI patients (n = 6), 194 
musculoskeletal disease patients (n = 3), and patients with other diseases (n = 9) were 1.41, 0.78, 195 
2.43, and 0.63, respectively. The results of the TUG test (n = 26; the patient in case 10 was 196 
unable to perform the test) and the BBS (n = 32) indicated improvement after the 16 training 197 
sessions, but these improvements were not statistically significant. The mean decrease (Cohen d) 198 
in the TUG test was 6.4 ± 16.4 s (d = 0.39). Twenty-one of 26 patients were faster after training, 199 
and 5 patients were slower (cases 5, 13, 30, 31, and 36) (fig 5). The mean increase (Cohen d) in 200 
BBS was 1.9 ± 5.5 (d = 0.35). Nineteen of 32 patients had higher scores compared to baseline; 201 
no change was observed in 6 (cases 12, 17, 23, 27, 36, and 37), and 7 had lower scores (cases 11, 202 
16, 26, 30, 31, 32, and 34) (fig 6).  203 
 204 
DISCUSSION 205 
 206 
We investigated the feasibility of rehabilitation using a robot suit HAL. We demonstrated that 207 
HAL rehabilitation could be implemented safely and effectively. Although a few patients 208 
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developed lumbar or knee pain during the training, no serious training-related adverse events 209 
occurred. Significant improvements in gait speed, number of steps, and cadence were observed, 210 
as assessed by the 10MWT. Improved TUG test and BBS results were also observed, but 211 
because of the small sample size of this pilot study, these improvements were not statistically 212 
significant. Overall, our results suggest that HAL rehabilitation has the potential to improve 213 
ambulation in patients with limited mobility. 214 
 215 
Two patients (cases 15 and 21) dropped out for medical reasons. One developed lumbar pain 216 
(case 21), and 1 experienced a relapse of neuropathic pain due to SCI (case 15). Although it is 217 
unclear whether there was a causal relationship between HAL training and the pain that 218 
developed, the lumbar pain in case 21 had been persistent before the HAL training and even after 219 
the training ended, and the neuropathic pain in case 15 followed a previous pattern of symptom 220 
flares associated with seasonal change. Therefore, it is likely that HAL training did not directly 221 
cause the pain that developed in these 2 cases. Two other patients complained of knee pain 222 
during the training period, but this pain was not severe, and the patients were able to complete 223 
the training. Although, once again, direct causality is unclear, safe implementation of HAL 224 
rehabilitation requires adequate caution on the part of therapists and self-awareness on the part of 225 
patients who have lumbar and knee pain. Regarding feasibility, approximately 10 min was 226 
required for 2 to 3 therapists to put electrodes and the HAL suit on or off the patient. This 227 
procedure is a slight inconvenience to address but not a major obstacle to HAL rehabilitation. 228 
 229 
Significant improvements in functional ambulation were observed, and the effect sizes (Cohen d) 230 
for gait speed, number of steps, and cadence were 0.82, 0.61, and 0.96, respectively. The 231 
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correlation coefficient for gait speed with cadence was higher than that of gait speed with steps (r 232 
= 0.73 vs. r = 0.30). Therefore, the improvement in gait speed with HAL training was mainly 233 
brought about by improvement in cadence. That is, HAL training improved stride frequency 234 
more than stride length. This finding agrees with a previous robotic training study.19 The effect 235 
sizes for the TUG test and BBS were smaller than that effect sizes for the 10MWT. This result 236 
seems to occur because the TUG test and BBS involve complicated motions such as moving 237 
from sitting to standing, walking and returning, reaching forward, and alternating feet on each 238 
step. The effect sizes for gait speed in 9 stroke patients and in 6 SCI patients were large (1.41 239 
and 0.78), respectively. Therefore, training effectiveness in stroke and SCI patients can be 240 
expected. The effect size in 3 patients with musculoskeletal diseases was also large (2.43), but 241 
the number of patients was small. Therefore, further studies are needed. In this study, we 242 
recruited patients with a wide range of stroke and SCI severities. Future studies should examine 243 
the influence of the severity of stroke and SCI on the effectiveness of HAL rehabilitation. 244 
 245 
Many recent studies have reported the efficacy of robot-assisted rehabilitation. It is very difficult 246 
to directly compare these studies and our study, due to differences in diseases, severity and 247 
duration of the disorder, robotic features, methods of intervention, and outcome measures.20 Wirz 248 
et al. reported that after locomotor training with Lokomat, the 10MWT gait speed of 20 patients 249 
with chronic incomplete SCI increased by 0.11 ± 0.10 m/s (d = 1.10).21 The number of SCI 250 
patients in our study was limited to 6, but our results also indicate the efficacy of HAL 251 
rehabilitation for these patients (d = 0.78). Hornby et al. reported that after robotic-assisted 252 
locomotor training, the gait speed in chronic stroke patients increased by 0.07 ± 0.07 m/s (d = 253 
1.0).11 Our results also indicate the efficacy of HAL rehabilitation for 9 chronic stroke patients (d 254 
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= 1.41). We conjectured that the mechanism of this recovery of functional ambulation was due to 255 
changes in plasticity in the spinal cord and supraspinal centers. Appropriate sensory inputs, such 256 
as maximum weight loading, facilitating proper trunk posture, and hip extension, are essential for 257 
maximizing functional recovery.22 Our experience with HAL indicates that the HAL-induced 258 
motion might evoke the sensory input, which has a favorable feedback effect on the central 259 
nervous system for a recovery of locomotor function. In addition, even if a patient’s condition 260 
were too severe for medical therapists to provide adequate rehabilitation training, HAL might 261 
still make adequate training possible. HAL is a robotic device with potential rehabilitation 262 
applications that are dependent on the physical support it can provide. 263 
 264 
Study Limitations 265 
 266 
This study was not a randomized controlled trial and could not compare the efficacy of HAL 267 
training with conventional rehabilitation. Second, long-term efficacy was not assessed after HAL 268 
training. Third, this study could not exclude observer bias and subject bias because the same staff 269 
implemented assessment and training, and approximately half of the patients were recruited 270 
through local newspaper advertisements. Finally, the statistical power was low because of the 271 
small number of patients with each disease. 272 
 273 
CONCLUSIONS 274 
 275 
This quasi-experimental study revealed the feasibility of HAL training for rehabilitating patients 276 
with limited mobility. This study has shown that it is possible to manage 8 weeks of 277 
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rehabilitation with HAL training (16 sessions of 90 minutes) safely and effectively, even with 278 
persons who received their diagnosis many years ago. After HAL training, significant 279 
improvements in gait speed, number of steps, and cadence were observed. Although 280 
improvements were observed in the TUG test and BBS, they were not statistically significant. 281 
There were no serious adverse events. Further studies are needed to compare the effectiveness of 282 
HAL training and conventional rehabilitation. 283 
284 
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 345 
FIGURE LEGENDS 346 
Figure 1. The robot suit HAL. 347 
Figure 2. Change in 10MWT gait speed for 27 patients after HAL training. 348 
Figure 3. Change in number of steps during 10MWT for 27 patients after HAL training. 349 
Figure 4. Change in 10MWT cadence for 27 patients after HAL training. 350 
Figure 5. Change in TUG test results for 26 patients after HAL training. 351 
Figure 6. Change in BBS score for 32 patients after HAL training. 352 
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Figure 6. 
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Table 1: Clinical characteristics of patients
Case No.Age (y) Sex Diagnosis Paralysis type Duration sincedisease Ambulation Assistive device Orthosis Training
Duration of
training
(wk)
Adverse events
1 69 M stroke (cerebral infarcts) paraplegia 15y independently t-cane AFO dropout
(personal reason)
ND Nothing
2 61 M stroke (cerebral hemorrhage) paraplegia 14y8mo independently t-cane AFO dropout
(personal reason)
ND Nothing
3 65 M stroke (cerebral hemorrhage) hemiplegia 2y2mo supervision quad-cane AFO complete 8 Nothing
4 37 F stroke (cerebral hemorrhage) quadriplegia 16y independently NA AFO complete 8 Nothing
5 72 M stroke (cerebral infarcts) hemiplegia 2y9mo supervision t-cane AFO complete 8 Nothing
6 54 M stroke (cerebral hemorrhage) hemiplegia 1y1mo supervision t-cane NA complete 8 Nothing
7 63 F stroke (cerebral hemorrhage) hemiplegia 1y6mo independently t-cane AFO complete 15 knee pain
(patellar tendinitis)
8 52 M stroke (cerebral hemorrhage) ataxia 2y2mo NA NA NA complete 12 Nothing
9 74 M stroke (cerebral infarcts) hemiplegia 3y4mo independently t-cane AFO complete 9 Nothing
10 53 M stroke (subarachnoid hemorrhage,
cerebral infarcts)
hemiplegia ND supervision pick up walker KAFO complete 9 Nothing
11 18 M stroke (moyamoya disease) hemiplegia 11y independently NA AFO complete 21 Nothing
12 64 M stroke (cerebral hemorrhage) hemiplegia 1y supervision t-cane AFO complete 8 Nothing
13 58 F SCI (incomplete) quadriplegia 3y3mo supervision lateral crutch KAFO complete 8 Nothing
14 69 M SCI (incomplete) quadriplegia 1y3mo supervision pick up walker AFO complete 8 Nothing
15 43 M SCI (incomplete) paraplegia 3y3mo NA NA KAFO dropout
(medical reason)
ND neuropathic pain
after SCI
16 59 M SCI (spina bifida) paraplegia 6y4mo supervision t-cane NA complete 8 Nothing
17 31 M SCI (complete) paraplegia 3y NA NA NA complete 10 Nothing
18 64 F SCI (incomplete) quadriplegia 2y independently t-cane AFO complete 9 Nothing
19 54 M SCI (central cervical cord injury) quadriplegia 5y supervision t-cane NA complete 12 Nothing
20 47 M
SCI (spinal dural arteriovenous
fistula) paraplegia 1y1mo independently bilateral crutch AFO complete 8 Nothing
21 74 F
musculoskeletal disease (cervical
spondylotic myelopathy) quadriplegia ND independently bilateral crutch NA
dropout
(medical reason) ND low back pain
22 81 F musculoskeletal disease (OA Knee) NA ND independently NA NA complete 10 Nothing
23 44 M musculoskeletal disease (OA Knee) NA ND independently NA NA complete 11 Nothing
24 74 M musculoskeletal disease (OA Knee) NA ND independently NA NA complete 10 Nothing
25 62 M Parkinson’s disease NA 8y independently NA NA complete 11 Nothing
26 72 F Parkinson’s disease NA 7y8mo independently NA NA complete 9 Nothing
27 36 M gonadotropin-dependent myopathy paraplegia 19y NA NA NA complete 8 Nothing
28 52 F limb-girdle muscular dystrophy quadriplegia 24y supervision t-cane NA complete 9 Nothing
29 57 F muscular dystrophy NA 44y independently NA NA dropout
(personal reason)
ND Nothing
30 67 M limb-girdle muscular dystrophy NA 28y independently t-cane NA complete 8 Nothing
31 73 M inclusion body myositis NA 10y independently t-cane NA complete 10 knee pain
32 24 M traumatic brain injury quadriplegia 17y1mo supervision walker NA complete 8 Nothing
33 19 F traumatic brain injury quadriplegia 6y2mo assistance pick up walker KAFO complete 8 Nothing
34 29 F traumatic brain injury quadriplegia 10y7mo assistance pick up walker KAFO complete 9 Nothing
35 20 M disuse syndrome,
secondary to malignant lymphoma
NA 3y9mo independently t-cane NA dropout
(personal reason)
ND Nothing
36 31 F cerebral palsy quadriplegia 30y10mo independently lateral crutch NA complete 10 Nothing
37 55 M sequelae of poliomyelitis paraplegia 54y independently lateral crutch NA complete 19 Nothing
38 48 F hypoxic ischemic encephalopathy quadriplegia 2y assistance NA NA complete 12 Nothing
NOTE.
Abbreviations: AFO, ankle-foot orthosis; F, female; KAFO, knee-ankle-foot orthosis; M, male; NA, not applicable; ND, no data; OA, osteoarthritis
Baseline After the training DifferenceMean (95% CI) P-value n
Speed (m/sec) 0.52 ± 0.40 0.61 ± 0.43 0.09 (0.05 to 0.14) p < 0.001 27
Steps 34.0 ± 20.4 31.0 ± 18.8 -3.0 (-4.9 to -1.0) p < 0.001 27
Cadence (steps/min) 74.3 ± 34.1 81.1 ± 32.9 6.8 (4.0 to 9.6) p < 0.001 27
43.7 ± 45.0 37.3 ± 34.1 -6.4 (-13.0 to 0.2) 0.057 26
33.6 ± 16.9 35.5 ± 16.3 1.9 (-0.1 to 3.9) 0.059 32
NOTE. Values expressed as mean ± SD.
Abbreviation: TUG, Timed-Up and Go. BBS, Berg Balance Scale.
Table 2: Functional ambulation and balance ability at the baseline and after the 16-session HAL training
Outcome measurements
10 MWT
TUG (sec)
BBS
